Fail safe: Changing a broken approach to patient medication safety

In The News | Jul 21, 2022

Jacques Turgeon, BPharm, PhD, TRHC Chief Scientific Officer and CEO of Precision Pharmacotherapy Research and Development Institute, co-authored an article for Drug Store News that outlines how the traditional approach to medication safety lacks precision, personalization, and proactive analysis. Importantly, the traditional approach uses multiple one-to-one drug analyses, ignoring simultaneous, multi-drug interactions. As a result, the approach leaves patients at risk for avoidable adverse drug events.

Share this:

About the Author

Media Relations

Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including MedWise® Science, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based care.

Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4